Table 2 characteristics of the study population with statin according to the group
One risk factor (statin alone) n = 3,560 | Two risk factors* n = 5,072 | At least three risk factors* n = 7,765 | Total n = 16,397 | |||||
|---|---|---|---|---|---|---|---|---|
Demographic characteristics | ||||||||
Male (%) | 1,139 | (37.6) | 2,374 | (46.8) | 4,097 | (52.8) | 7,810 | (47.6) |
Age | (10.1) | 31.2 | (9.5) | |||||
Mean (sd) | 45.3 | (9.7) | 58.8 | (10.9) | 69.0 | |||
Median | 46 | 59 | 69.0 | |||||
Extremes | 2-59 | 2-95 | 18-102 | |||||
Vital status | ||||||||
Number of deaths during the study period (%) | 13 (0.37) | 34 (0.67) | 294 (3.79) | |||||
Mean delay of occurrence (death), months | 310 | 284 | 283 | |||||
(Min-max delay, days) | (188-433) | (224-345) | (262-304) | |||||